medigraphic.com
ISSN 1561-2988 (Print)

2021, Number 1

<< Back Next >>

Rev Cubana Farm 2021; 54 (1)

Prescription quality for patients with ischemic heart disease

Gutiérrez TLE, Díaz MM, Polo VJC

Language: Spanish
References: 15
Page: 1-15
PDF size: 562.09 Kb.


ABSTRACT

Introduction: Ischemic heart disease is one of the leading causes of morbidity in Cuba. There are no recent references of utilisation studies evaluating the quality of drugs prescription for the treatment of this disease at the Institute of Cardiology and Cardiovascular Surgery in Havana, which is a national reference center.
Objective: To assess the quality of the prescription to patients with ischemic heart disease at the Institute of Cardiology and Cardiovascular Surgery in Havana during the second half of 2018.
Methods: A study was carried out with the following approaches: observational, descriptive, cross-sectional, of indication-prescription kind of drugs use, and with elements of therapeutic scheme. The sample was of 120 patients, intentionally selected, from a population of 600. The measured variables were: age, sex, skin color, personal pathological history, risk factors, diagnosis, prescribed drugs, indication, therapeutic scheme, individualization of treatment and quality of prescription, collected from medical records. To establish possible associations among variables, the squared ji test was used for contingency tables.
Results: A predominance of white skin, male older adults, with a history of high blood pressure, previous cardiovascular events and smoking habit were found as a risk factor. The most commonly used drugs were antihypertensives, platelet antiaggregates, anticoagulants and anti-anginal ones, in a combined way. The quality of the prescription was adequate in 70.8% of patients, which was mainly affected by a non-individualized treatment.
Conclusions: Ischemic heart disease has a high associated morbidity and its pharmacological approach requires the use of a large number of drugs, so it is very important to make an individualized prescription that avoids as much as possible the appearance of risky drug interactions, thus helping to raise the quality of life of the patient.


REFERENCES

  1. Ibáñez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci Ch, Bueno H, et al.Guía ESC 2017 sobre el tratamiento del infarto agudo de miocardio en pacientescon elevación del segmento ST. Rev Esp Cardiol 2017 [acceso12/12/2019];70(12):1-61. Disponible en:https://www.revespcardiol.org/index.php?p=revista&tipo=pdfsimple&pii=S0300893217306693

  2. Alcalá J, Maicas C, Hernández P, Rodríguez L. Cardiopatía isquémica:concepto, clasificación, epidemiología, factores de riesgo, pronóstico yprevención. Medicine; 2017 [acceso 12/12/2019];12(36). Disponible en:https://www.clinicalkey.es/#!/content/journal/1-s2.0S0304541217301567.

  3. Dirección Nacional de Registros Médicos y Estadísticos de Salud. AnuarioEstadístico de la Salud 2014. La Habana: Ministerio de Salud Pública; 2017.[acceso 04/03/2019]. Disponible en: http://www.sld.cu/sitios/dne/

  4. Cáceres F, Ramírez R. Protocolo de tratamiento de la cardiopatía isquémicaen la atención primaria de salud. Rev Cub Farm. 2002 [acceso12/12/2019];36(1):69-72. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75152002000100010&1ng=es.

  5. Calvo D, Delgado I, Alonso P, Pérez J, Furones J, Lara C, et al. FormularioNacional de Medicamentos. Dirección Nacional de Medicamentos. La Habana:MINSAP: Ecimed; 2019 [acceso 12/12/2019]. Disponible en:http://fnmedicamentos.sld.cu/index.php?P=aplicacionAndroid.

  6. Pérez MD, León JL, Dueñas A, Alfonzo JP, Navarro DA, de la Noval R, et al.Guía cubana de diagnóstico, evaluación y tratamiento de la hipertensiónarterial. Rev Cub Med. 2017 [acceso 15/12/2020];56(4):242-321. Disponible en:http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0034-75232017000400001&lng=es.

  7. Quenta Tarqui RR, Madiedo Oropesa A. Caracterización epidemiológica de laHTA en un Consultorio Médico del municipio Viñales. CorSalud. 2016 [acceso12/12/2019];8(4):235-40. Disponible en:http://www.revcorsalud.sld.cu/index.php/cors/article/view/197

  8. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Böhm M, et al. Guíade práctica clínica de la ESH/ESC para el manejo de la hipertensión arterial2013. Hipertens Riesgo Vasc. 2013 [acceso 10/01/2021];30(Supl 3):4-9.Disponible en: https://www.revespcardiol.org/es-guia-practica-clinica-esh-escel-articulo-S0300893213004120

  9. Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, et al. Comitéde Estadísticas y Subcomité de Estadísticas de Ataque Cerebral de la AmericanHeart Association. Estadísticas de enfermedad cardíaca y de ataque cerebral2017. American Heart Association. Circulation 2017;135:146-603. DOI: 10.1161/CIR.0000000000000485

  10. Saldarriaga C, Bedoya L, Gómez L, Hurtado L, Mejía J, González N.Conocimiento del riesgo de presentar un infarto de miocardio y las barreras parael acceso al estilo de vida saludable. Rev Colomb Cardiol. 2016 [acceso10/03/2019];23(3):163-7. Disponible en:http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0120-56332016000300002&lng=en. http://dx.doi.org/10.1016/j.rccar.2015.07.005

  11. Feng A, Peña Y, Li W. La cardiopatía isquémica en pacientes diabéticos y nodiabéticos. Rev Haban Cienc Méd. 2017 [acceso 10/03/2019];16(2):217-28.Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1729-519X2017000200008&lng=es

  12. Merck Sharp, Dohme Corp. Manual MSD Conocimiento Médico; Kenilworth,NJ: Merck & Co. Inc; 2020 [acceso 05/03/2020]. Disponible en:https://www.msdmanuals.com

  13. Grabmaier U, Rizas K, Berghof J, Huflaender Y, Wiegers C, Wakili R, et al.Association between survival and non‑selective prehospital aspirin and heparinadministration in patients with out‑of‑hospital cardiac arrest: a propensityscore‑matched analysis. Intensive Care Med. 2018;44(4):537-39. DOI:10.1007/s00134-018-5111-2

  14. Aljadani R, Aseeri M. Prevalence of drug–drug interactions in geriatricpatients at an ambulatory care pharmacy in a tertiary care teaching hospital.BMC Res Notes 2018;11:234. DOI: 10.1186/s13104-018-3342-5

  15. Teka F, Teklay G, Ayalew E, Teshome T. Potential drug–drug interactionsamong elderly patients admitted to medical ward of Ayder Referral Hospital,Northern Ethiopia: a cross sectional study. BMC Res Notes. 2016 [acceso05/04/2020];9:431. Disponible en http://creativecommons.org/publicdomain




2020     |     www.medigraphic.com